MONALEESA-2: improved OS seen in HR+ advanced breast cancer treated with ribociclib + letrozole VJOncology 1:19 2 years ago 318 Скачать Далее
MONALEESA-2: ribociclib + letrozole in pts with de novo metastatic disease and late recurrence VJOncology 1:29 1 year ago 610 Скачать Далее
ESMO 2016: Press brief on the MONALEESA-2 clinical trial on breast cancer VJOncology 9:39 7 years ago 1 160 Скачать Далее
Early RIBECCA results: ribociclib with letrozole for metastatic breast cancer VJOncology 1:40 5 years ago 985 Скачать Далее
Safety and efficacy of ribociclib and letrozole in advanced breast cancer – the MONALEESA-2 trial VJOncology 2:49 7 years ago 2 504 Скачать Далее
Expert Perspectives: CDK 4/6 Inhibitors for ER+ Breast Cancer: Emerging Data and Future Implications HMP Education 10:02 8 years ago 1 812 Скачать Далее
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer Coby Herd 53:42 7 years ago 1 364 Скачать Далее
Novel Therapeutics for Breast Cancer: CDK Inhibitors, Immunotherapy, and Role of TILs HMP Education 31:56 7 years ago 686 Скачать Далее
